Income affects oncology clinical trial participation

January 16, 2013
Income affects oncology clinical trial participation
Oncology patients with lower income, even older patients with access to Medicare, are significantly less likely to participate in clinical trials, according to research published online Jan. 7 in the Journal of Clinical Oncology.

(HealthDay)—Oncology patients with lower income, even older patients with access to Medicare, are significantly less likely to participate in clinical trials, according to research published online Jan. 7 in the Journal of Clinical Oncology.

Joseph M. Unger, Ph.C., of the Fred Hutchison Cancer Research Center in Seattle, and colleagues assessed clinical trial participation patterns according to socioeconomic and demographic factors for 5,499 using an Internet-based treatment .

The researchers found that 40 percent of patients discussed clinical trials with their physicians; of these discussions, 45 percent led to offers of clinical trial participation, and about half (51 percent) of these offers led to participation in clinical trials. Overall, the rate of participation in clinical trials was 9 percent. Based on univariate analysis, participation was significantly less likely for older patients and patients with lower income and education. Income remained a significant predictor of clinical trial participation in multivariable analysis (odds ratio, 0.73). For patients aged 65 years and older with universal access to Medicare, lower income still predicted lower participation in trials. Among lower-income patients, cost concerns were more evident.

"Because clinical trials offer the newest cancer treatments, equal access to this important resource for patients of all income groups is essential. Also, improved lower-income participation would allow clinical trials to be conducted more quickly and would better ensure the applicability of trial results to all income levels (i.e., generalizability)," the authors write. "Understanding that income is related to clinical trial participation could help guide aimed at increasing access for lower-income patients."

One author disclosed to NexCura.

Explore further: Lower income cancer patients less likely to be involved in clinical trials

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Lower income cancer patients less likely to be involved in clinical trials

June 3, 2012
Cancer patients with annual household incomes below $50,000 were less likely to participate in clinical trials than patients with annual incomes of $50,000 or higher, and were more likely to be concerned about how to pay ...

Psychoeducational intervention changes patient attitudes on clinical trials participation

June 13, 2012
Seeking ways to change cancer patients' perceptions and negative attitudes towards clinical trials participation, researchers at Moffitt Cancer Center conducted a study offering two different kinds of intervention to two ...

Black patients received less clinical trial information than white patients

October 29, 2012
A study comparing how physicians discuss clinical trials during clinical interactions with black patients versus white patients further confirms racial disparities in the quality of communication between physicians and patients.

Socioeconomic status affects cancer trial referrals

December 7, 2012
(HealthDay)—Patients of lower socioeconomic status are less likely to be referred to participate in early-phase cancer trials compared with patients of higher socioeconomic status, according to research published online ...

Women and minorities face barriers to clinical trials

June 1, 2012
Physicians have great influence over whether minorities and women participate in cancer clinical trials, according to a new literature review.

Recommended for you

New study shows how cells can be led down non-cancer path

October 23, 2017
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells. In a ...

Microbiologists contribute to possible new anti-TB treatment path

October 23, 2017
As part of the long effort to improve treatment of tuberculosis (TB), microbiologists led by Yasu Morita at the University of Massachusetts Amherst report that they have for the first time characterized a protein involved ...

Major study of genetics of breast cancer provides clues to mechanisms behind the disease

October 23, 2017
Seventy-two new genetic variants that contribute to the risk of developing breast cancer have been identified by a major international collaboration involving hundreds of researchers worldwide.

Proton therapy lowers treatment side effects in pediatric head and neck cancer patients

October 23, 2017
Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional photon radiation, and it will result in similar outcomes with less impact on quality of life. Researchers from ...

Big Data shows how cancer interacts with its surroundings

October 23, 2017
By combining data from sources that at first seemed to be incompatible, UC San Francisco researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they ...

Symptom burden may increase hospital length of stay, readmission risk in advanced cancer

October 23, 2017
Hospitalized patients with advanced cancer who report more intense and numerous physical and psychological symptoms appear to be at risk for longer hospital stays and unplanned hospital readmissions. The report from a Massachusetts ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.